These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10464307)

  • 21. Effects of different expression systems on characterization of adenylate deaminase from Aspergillus oryzae.
    Ke C; Li S; Cui Y; Qiu H; Pang Z
    Bioprocess Biosyst Eng; 2020 May; 43(5):919-926. PubMed ID: 32020448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymes of adenylate metabolism and their role in hibernation of the white-tailed prairie dog, Cynomys leucurus.
    English TE; Storey KB
    Arch Biochem Biophys; 2000 Apr; 376(1):91-100. PubMed ID: 10729194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel aspects of tetramer assembly and N-terminal domain structure and function are revealed by recombinant expression of human AMP deaminase isoforms.
    Mahnke-Zizelman DK; Tullson PC; Sabina RL
    J Biol Chem; 1998 Dec; 273(52):35118-25. PubMed ID: 9857047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering the phosphoinositide-binding profile of a class I pleckstrin homology domain.
    Cozier GE; Bouyoucef D; Cullen PJ
    J Biol Chem; 2003 Oct; 278(41):39489-96. PubMed ID: 12885767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the metallocenter of rabbit skeletal muscle AMP deaminase. Evidence for a dinuclear zinc site.
    Mangani S; Benvenuti M; Moir AJ; Ranieri-Raggi M; Martini D; Sabbatini AR; Raggi A
    Biochim Biophys Acta; 2007 Feb; 1774(2):312-22. PubMed ID: 17254852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism and structure based design of inhibitors of AMP and adenosine deaminase.
    Lindell SD; Maechling S; Klein R; Freigang J; Laber B; Blanazs L; Leonhardt M; Haupt S; Petry T; Sabina RL
    Bioorg Med Chem; 2021 Aug; 43():116272. PubMed ID: 34157570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Normal activities of AMP-deaminase and adenylate kinase in patients with McArdle disease.
    Joshi PR; Apitz T; Zierz S
    Neurol Res; 2016 Dec; 38(12):1052-1055. PubMed ID: 27760513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains.
    Kavran JM; Klein DE; Lee A; Falasca M; Isakoff SJ; Skolnik EY; Lemmon MA
    J Biol Chem; 1998 Nov; 273(46):30497-508. PubMed ID: 9804818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overproduction, Purification and Characterization of Adenylate Deaminase from Aspergillus oryzae.
    Li S; Qian Y; Liang Y; Chen X; Zhao M; Guo Y; Pang Z
    Appl Biochem Biotechnol; 2016 Dec; 180(8):1635-1643. PubMed ID: 27539573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of adenosine 5'-monophosphate deaminase--the key enzyme responsible for the umami taste of nori (Porphyra yezoensis Ueda, Rhodophyta).
    Minami S; Sato M; Shiraiwa Y; Iwamoto K
    Mar Biotechnol (NY); 2011 Dec; 13(6):1140-7. PubMed ID: 21519809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase B and their influence on kinase activity.
    Frech M; Andjelkovic M; Ingley E; Reddy KK; Falck JR; Hemmings BA
    J Biol Chem; 1997 Mar; 272(13):8474-81. PubMed ID: 9079675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of functional domains in AMPD1 by mutational analysis.
    Gross M; Morisaki H; Morisaki T; Holmes EW
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1010-7. PubMed ID: 7802626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of AMP deaminase in rat hearts subjected to ischemia and reperfusion by purine riboside.
    Borkowski T; Lipinski M; Kaminski R; Krzyminska-Stasiuk E; Langowska M; Raczak G; Slominska EM; Smolenski RT
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):876-80. PubMed ID: 18600556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and kinetic alterations of muscle AMP deaminase during chronic creatine depletion.
    Rush JW; Tullson PC; Terjung RL
    Am J Physiol; 1998 Feb; 274(2):C465-71. PubMed ID: 9486137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and physiological investigations on adenosine 5' monophosphate deaminase from Plasmodium spp.
    Nagappa LK; Singh D; Dey S; Kumar KA; Balaram H
    Mol Microbiol; 2019 Aug; 112(2):699-717. PubMed ID: 31132185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression patterns of AMP-deaminase and cytosolic 5'-nucleotidase genes in human term placenta.
    Roszkowska A; Klimek J; Kaletha K
    Mol Cell Biochem; 2008 Apr; 311(1-2):249-51. PubMed ID: 18165923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment.
    Qiu FH; Wada K; Stahl GL; Serhan CN
    Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4267-72. PubMed ID: 10760293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of pharmacological AMP deaminase inhibition and Ampd1 deletion on nucleotide levels and AMPK activation in contracting skeletal muscle.
    Plaideau C; Lai YC; Kviklyte S; Zanou N; Löfgren L; Andersén H; Vertommen D; Gailly P; Hue L; Bohlooly-Y M; Hallén S; Rider MH
    Chem Biol; 2014 Nov; 21(11):1497-1510. PubMed ID: 25459662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP-deaminase from thymus of patients with myasthenia gravis.
    Rybakowska I; Szydłowska M; Szrok S; Bakuła S; Kaletha K
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(3):229-34. PubMed ID: 25710358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular determinants in pleckstrin homology domains that allow specific recognition of phosphoinositides.
    Lemmon MA; Ferguson KM
    Biochem Soc Trans; 2001 Aug; 29(Pt 4):377-84. PubMed ID: 11497993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.